Plasma cathepsin L: A prognostic marker for pancreatic cancer

doi:10.3748/wjg.v20.i46.17532

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 46

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6483)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

376

WORD

237

HTML

3269

Figures (1-6)

210

Tables (1-4)

166

Sum=4258

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1071

Download

1154

Sum=2225

Dec 14, 2014 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Dec 14, 2014; 20(46): 17532-17540
Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17532

Table 1 Summary of clinical parameters of the patients with carcinoma of pancreas (n = 127)

Clinical parameters	n (%)
Pain	93 (73.2)
Jaundice	83 (65.4)
Anorexia	106 (83.5)
Wt. Loss	107 (84.3)
Diabetes	38 (30.0)
Chronic pancreatitis history	17 (13.4)
Common bile Duct dilated	84 (66.0)
Main Pancreatic Duct dilated	98 (77.2)
Locally advanced disease	87 (68.5)
Lymphatic invasion	50 (39.4)
Vascular encasement	59 (46.5)
Metastasis	52 (41.0)
Resectability	25 (19.6)
Chemotherapy	59 (46.5)

Citation: Singh N, Das P, Gupta S, Sachdev V, Srivasatava S, Datta Gupta S, Pandey RM, Sahni P, Chauhan SS, Saraya A. Plasma cathepsin L: A prognostic marker for pancreatic cancer. World J Gastroenterol 2014; 20(46): 17532-17540
URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17532.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i46.17532